arrow
J

Joanne Xiu

caris life sciences
H指数:37
被引数:6,647

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Whole-exome sequencing provides assessment of homologous recombination deficiency for identification of PARPi-responsive ovarian tumors” [Gynecol. Oncol. 197 (2025) 139–145]

勘误:“全外显子组测序为评估同源重组缺陷以识别对PARPi敏感的卵巢肿瘤” [Gynecol. Oncol. 197 (2025) 139–145]

2026-10-210
PRE
Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer

HER2低表达、HER2超低表达和HER2缺失型男性乳腺癌的分子和免疫图谱分析

Breast
IF7.9
2026-08-010
PRE
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset

食管癌(EC)的基因组分析识别出组蛋白甲基转移酶的复发突变作为一个独特亚群

2026-07-110
OA
Author Correction: Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer

作者更正:AI协同H&E和IHC图像分析预测结直肠癌和乳腺癌的癌症生物标志物和生存结局

2025-10-240
OA
Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer

人工智能协同分析H&E与IHC图像,预测结直肠癌和乳腺癌的癌生物标志物及生存结局

2025-08-010
OAAI
BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma

BRAF/MEK抑制诱导BRAFV600E突变型胶质瘤细胞状态转变,增强免疫检查点敏感性

2025-06-120
OA
Inhibition of Mitochondrial-Associated Protein MAGMAS Resensitizes Chemoresistant Prostate Cancer Cells to Docetaxel

抑制线粒体相关蛋白MAGMAS可重新使耐药性前列腺癌细胞对多西他赛敏感

CANCERS
IF4.4
2025-04-300
OA
Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes
2024-12-300
PRE
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation

突变负担和抗PD-1疗效与免疫细胞浸润或淋巴样细胞激活之间并非普遍相关。

2024-12-010
PRE